We are live on ! Find out more
PGEN icon

Precigen

166 hedge funds and large institutions have $1.66B invested in Precigen in 2018 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 68 increasing their positions, 35 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

128% more call options, than puts

Call options by funds: $32.2M | Put options by funds: $14.1M

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

94% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 35

47% more capital invested

Capital invested by funds: $1.13B → $1.66B (+$529M)

15% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 27

2.66% more ownership

Funds ownership: 81.07%83.73% (+2.7%)

2% more funds holding

Funds holding: 162166 (+4)

Holders
166
Holders Change
+4
Holders Change %
+2.47%
% of All Funds
3.8%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
31
Increased
68
Reduced
35
Closed
27
Calls
$32.2M
Puts
$14.1M
Net Calls
+$18.1M
Net Calls Change
+$17.7M

PGEN Hedge Fund Activity: Q1 2018 in Review

166 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q1 2018, worth a combined $1.66B — up 47% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PGEN positions and 27 closed out — a net gain of 4 holders — while 68 added to existing stakes and 35 trimmed.

The largest buyer was Iridian Asset Management, adding an estimated $28.7M. The largest seller was D.E. Shaw & Co, cutting an estimated $4.33M.

  • 166 institutional investors held Precigen (PGEN) as of Q1 2018, up from 162 in Q4 2017.
  • Funds reported $1.66B of Precigen stock for Q1 2018, up 47% quarter-over-quarter.
  • 31 funds opened new Precigen positions in Q1 2018 and 27 closed out, a net change of +4 holders.
  • The largest Precigen buyer in Q1 2018 was Iridian Asset Management, an estimated $28.7M added.
  • The largest Precigen seller in Q1 2018 was D.E. Shaw & Co, an estimated $4.33M sold.

Based on aggregated 13F filings for Q1 2018.